Vancouver, British Columbia--(Newsfile Corp. - July 7, 2025) - NervGen Pharma Corp. (NGEN:CA) (OTCQB: NGENF) ("NervGen" or the "Company"), a clinical-stage biotech company dedicated to developing ...
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
The Pentagon quarterly program cost report documents schedule delays for the H-1 helicopter upgrade, MV-22 and Evolved Expendable Launch Vehicles, as well as a $1.4-billion cost increase for the Space ...
TKO Group Holdings, Inc. (NYSE: TKO) (“TKO” or the “Company”), a premium sports and entertainment company, today announced that its board of directors has authorized a significant increase to its ...
Broadcasters’ next Quarterly Issues/Programs List (“Quarterly List”) must be placed in stations’ Public Inspection Files by April 10, 2025, reflecting information for the months of January, February, ...
ATLANTA, Oct. 16, 2024 /PRNewswire/ -- MetroCity Bankshares, Inc. (the "Company") (NASDAQ: MCBS) announced today that its board of directors declared a quarterly cash dividend of $0.23 per share on ...
If more than 2.5% of the Fund’s outstanding common shares are tendered, the Fund will purchase its shares from tendering shareholders on a pro rata basis at a price equal to 98% of the Fund’s NAV per ...
Vancouver, British Columbia--(Newsfile Corp. - April 9, 2025) - NervGen Pharma Corp. (NGEN:CA) (OTCQB: NGENF) ("NervGen" or the "Company"), a clinical-stage biotech company dedicated to developing ...